Navigation Links
Clinical Trial Sponsors and CROs Standardize on the DrugDev Golden Number as the Universal Identifier for Global Investigators and Sites
Date:4/13/2016

Selecting the right investigators and sites to run a clinical trial has a direct impact on patient enrollment and retention, data integrity, study timelines and cost - and an effective site selection process begins with an accurate understanding of site and investigator data. DrugDev technology makes it easy for sponsors and CROs to make more evidence-based planning and site selection decisions by integrating information across an expanding set of internal and external sources.

DrugDev and Pfizer will host a webinar on April 14, 2016 at 12pm ET to describe how the Golden Number is transforming clinical trials. Click here to register or visit the DrugDev Knowledge Center after the session to view a recording of the live session once available.

The cloud-based platform matches and masters enormous volumes of data from numerous disparate sources – including internal records, the DrugDev Network, external partner databases, public data, and third-party lists – to generate a single and unified source of the truth with robust experience, performance and contact information. To enable integration, all data are matched to a universal identifier called the DrugDev Golden Number to uniquely identify investigators and sites across sources.

The Golden Number, currently being used by 8 of the top 10 pharmaceutical companies and several leading CROs, is the technology which powers the TransCelerate Investigator Registry and the Investigator Databank. Such wide-spread and growing adoption of this universal identifier drives standardization and promotes collaboration across clinical systems and throughout the industry.

This technology enables customers to improve investigator identification, strengthen site relationships, and take better advantage of collaboration opportunities with other sponsors already integrating the Golden Number into their clinical systems. Click here to learn more.

“DrugDev is not merely helping sponsors incrementally improve clinical trials – we are redefining the very fundamentals on which they are run,” said Ibs Mahmood, DrugDev President and CEO. “The only way I know to truly change efficiencies is to establish industry-wide data standards that simplify internal processes and encourage collaboration between sponsors, CROs, sites and vendors of all sizes. The DrugDev Golden Number is one concrete example of beautiful technology that accomplishes precisely what it’s meant to - it eliminates confusion and redundancy, and gives drug development experts the tools they need to run smart, efficient trials.”

Benefits for sponsors and CROs adopting the Golden Number include

  • Operational efficiencies – Make better decisions based on integration of all available site and study data, with more accurate contact information and auto-population of documents (e.g. surveys, CTAs)
  • Data mastering efforts – Create a single source of the truth with de-duplicated and cleaner records, and CTMS/data integration in the case of M&A or legacy systems
  • Collaboration – Enable data sharing between sponsors (e.g. TransCelerate, Investigator Databank), between sponsors and CROs (e.g. integration of site target and do not contact lists), and between industry and sites via profiles (e.g. researchers provide information once, for use by many)
  • Integrated reporting – Track cross-vendor activity and metrics, generate a consolidated view of current and historical study activity with investigators and sites, and manage financial/aggregate spend data for investigators and sites (e.g. to comply with the Sunshine Act)

“It’s thrilling to see how excited our customers are about using the DrugDev Golden Number to transform the way they perform master data management,” said Elisa Cascade, President of Data Solutions at DrugDev. “Sponsors tell us they expect the Golden Number to help them reduce the number of non-performing sites, decrease the need for rescue sites, reduce IT time and cost spent on data mastering, and improve site engagement – which in turn can streamline timelines and increase performance throughout the study. We are working with TransCelerate and Investigator Databank members, our partners, and direct sponsor and CRO clients every day to continue to refine the technology and the value it provides. The Golden Number is a significant milestone achievement that is bringing the entire industry together, and we are proud to be a small but significant part of this revolution in clinical trial transformation.”

About DrugDev

DrugDev’s unified clinical suite enables sponsors, CROs and sites to do more trials through industry-wide collaboration, standardization and a beautiful technology experience. Featuring solutions for global site payments, site identification and activation, workflow optimization, learning management, and site and patient engagement, DrugDev helps companies transform the quality and efficiency of clinical trials from startup through closeout. The company also powers the revolutionary TransCelerate Investigator Registry and Investigator Databank collaborations with the universal identifier known as the DrugDev Golden Number. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs trust DrugDev technology at drugdev.com.

Read the full story at http://www.prweb.com/releases/2016/04/prweb13339116.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. Award-Winning Clinical Research On Novel Optical Device Presented at the Annual Conference of the American Society for Laser Medicine and Surgery
2. REPRIEVE, Largest HIV-related Cardiovascular Disease Clinical Trial Ever, Enrolls More Than 1,000 Participants
3. Dr. Kimberly Farrell Joins Clinical Team at Advanced Dentistry of Scarsdale
4. ClinCapture Opens New Chapter of the BioTalks on April 26th, 2016 on Clinical Trial Design and Management in Park City, UT
5. Patient Perceptions and Best Practices in Clinical Trial Supply Management to be Presented by Catalent Executives at Upcoming Asian ISPE Conferences
6. Cambridge, UK, Workshop Will Discuss Accelerated Preclinical Drug Development and Readying Molecules for Phase I
7. Outcomes from SWHR’s Multi-stakeholder Workshop on Achieving Meaningful Subgroup Data in Clinical Trials Released
8. FDAnews Announces — Best Practices for Effective Pharma Technology Transfer: From R&D to Clinical to Commercial Webinar, April 25, 2016
9. TULA selected as the Finalist for the Best Sponsor-Focused Technological Development Category in Clinical & Research Excellence Awards 2016
10. Great Oaks Recovery Center Welcomes New Clinical Director
11. Venus Concept Receives Clearance by U.S. Food and Drug Administration for Venus Versa™ for over 20 Common Clinical Indications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2019)... ... August 21, 2019 , ... ... x-ray inspection technology: HDRX imaging. HDRX captures extremely high-resolution images of products ... can deliver high image resolution at normal production line speeds within power ...
(Date:8/19/2019)... LOUISVILLE, Ky. (PRWEB) , ... August 19, 2019 , ... ... prevent on-ice injuries through preventative physical therapy and to access to top-notch sports medical ... a PT group that understand the physical demands of ice skating, knows the individualized ...
(Date:8/17/2019)... ... 17, 2019 , ... Approximately 50 area youth between the ... a program sponsored by United Concordia Dental and Mission Arlington/Metroplex. , “We value ... to make these services available to area youths who are uninsured or underinsured,” ...
(Date:8/16/2019)... ... August 16, 2019 , ... ... handcrafted, one-of-a-kind children’s aircraft to Ronald McDonald House Charities in New Hyde Park, ... residents undergoing medical treatments and their family members a comfortable and fun way ...
(Date:8/15/2019)... (PRWEB) , ... August 15, 2019 , ... With many students either starting college for ... for this particular demographic. According to the CDC , “there are about 20 million ... are in people between the ages of 15 and 24. Young people are at greater ...
Breaking Medicine News(10 mins):
(Date:8/21/2019)... ... August 21, 2019 , ... Dr. Leonard Bley ... their newest laser ReLEx® SMILE (Small Incision Lenticule Extraction) located in their state-of-the-art Manhattan ... and SMILE in the Tri-State area. SMILE is a one-step, one laser procedure that ...
(Date:8/21/2019)... Israel (PRWEB) , ... August 21, 2019 , ... ... entering into a partnership to enhance cybersecurity workforce education and training. To commence ... simulated training platform for cybersecurity practitioners. Businesses in the United States now have ...
(Date:8/21/2019)... ... August 21, 2019 , ... Impact Advisors , a leading provider of ... it has been named to Inc. magazine’s Inc. 5000 list. The Inc. 5000 list ... significant percentage revenue growth. This year the firm was also named a 5-Time Inc. ...
Breaking Medicine Technology: